Results

Total Results: 14 records

Showing results for "analgesic".

1. Primary Care–Relevant Interventions to Prevent Opioid Use Disorder: Current Research and Evidence Gaps (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
   May 14, 2021 - drugs that act on one of the brain’s three main opioid receptor systems (mu, kappa, delta) and have analgesic … Introduction: FDA’s Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in … Approved Risk Evaluation and Mitigation Strategies (REMS) - Opioid Analgesic REMS. … Enhancing risk assessment in patients receiving chronic opioid analgesic therapy using natural language … Analgesic administration for patients with renal colic in the emergency department before and after

2. Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
   April 08, 2014 - Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms … Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study.

3. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
   April 08, 2014 - Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms … Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study.

4. Low-Dose Aspiring for the Prevention of Morbidity and Mortality from Preeclampsia: A Systematic Evidence Review fro the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/6W538pkN7ft6TsRMKfPWMJ
   May 27, 2014 - Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms … Analgesic use during pregnancy and risk of infant leukaemia: a Children’s Oncology Group study.

5. Evidence Summary: Ovarian Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
   February 13, 2018 - Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION

6. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
   February 13, 2018 - Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION

7. Archived: Final Evidence Summary: Depression in Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
   December 15, 2009 - vulnerable older adults or those with a history of gastrointestinal bleeding, given the prevalence of use of analgesic

8. Screening for Depression in Adult Patients in Primary Care Settings: An Update (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/-wqedxmwdpdE5BmzcBeTmn
   December 01, 2009 - vulnerable older adults or those with a history of gastrointestinal bleeding, given the prevalence of use of analgesic

9. Screening for Postmenopausal Osteoporosis: A Summary of the Evidence (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
   September 01, 2002 - Screening for Postmenopausal Osteoporosis: A Summary of the Evidence Epidemiology Half of all postmenopausal women will have an osteoporosis-related fracture during their lives, including one-quarter who will develop a vertebral deformity1 and 15% who will suffer a hip fracture.2 Hip fractures are associated with h…

10. Archived: Evidence Summary: Osteoporosis: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/osteoporosis-screening-2002
    September 17, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Osteoporosis: Screening, 2002 September 17, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They should not be constru…

11. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
    March 08, 2004 - most common complication of liver biopsy is pain; approximately 30 percent of patients require strong analgesic

12. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - Virus Infection complication of liver biopsy is pain; approximately 30% of patients require strong analgesic

13. Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2sssC_CV4u5DY_rgjC-FMd
    February 01, 2018 - Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION

14. Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16768/ovarian-cancer-final-evid-review/pdf
    February 01, 2018 - Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION